XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Option Plan (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity Stock option activity under the Company's 2019 Plan is set forth below: 
Number of
Options
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value (in thousands)
Outstanding, December 31, 20221,421,235 $12.94 7.09$483 
Granted— $— 
Exercised(93,335)$0.26 
Forfeited(31,019)$14.36 
Expired(277,805)$17.96 
Outstanding, March 31, 2023
1,019,076 $12.68 6.97$287 
Vested and expected to vest, March 31, 2023
1,019,076 $12.68 6.97$287 
Options exercisable, March 31, 2023
804,742 $12.80 6.64$287 
Schedule of Restricted Stock Unit Activity
Restricted stock unit activity under the Company's 2019 Plan is set forth below:
Number of
Shares
Weighted-
Average
Grant Date Fair Value
Aggregate
Intrinsic
Value (in thousands)
Outstanding, December 31, 20221,036,208 $7.28 $2,487 
Awards granted638,500 $2.30 
Awards released(113,720)$11.27 
Awards canceled(66,903)$11.37 
Outstanding, March 31, 2023
1,494,085 $4.66 $3,631 
Schedule of Non-cash Stock-based Compensation Expense
Total non-cash stock-based compensation expense recorded related to options granted, restricted stock units granted and stock purchase rights granted under the ESPP in the condensed statements of operations is as follows (in thousands):
 
 Three Months Ended March 31,
 20232022
Costs of revenue$53 $44 
Selling, general and administrative831 1,118 
Research and development102 214 
Total$986 $1,376